Summary. The present study concerns the effect of the experimental diabetogenic encephalomyocarditis (EMC) virus on normal and athymic nude mice of BALB/c origin. The effect of simultaneous immunosuppressive pharmacological treatment with a derivative of cyclophosphamide in a relatively low dose (3 mg/mouse) was also studied. After inoculation with EMC virus, 36% of the normal mice, but none of the nude mice, developed diabetes mellitus and 93% of the normal mice, but none of the nude mice, developed paresis of one or more leg(s). When lower doses of EMC virus were given, few or none of the normal mice developed diabetes or paresis. After treatment with a cyclophosphamide-derivative, the number of paralysed mice increased. EMC virus in abundant amounts could be isolated from the pancreas and heart of all virus-inoculated mice, including the non-diabetic nude mice.
This investigation concerns the effect of the experimental diabetogenic encephalomyocarditis (EMC) virus (M-strain) on the athymic nude mouse and on the normal, haired mouse of BALB/c origin. The purpose of the present investigation was to study the importance of the immune system in the development of diabetes in this animal model. Several human investigations have suggested that the immune system might play a pathogenic role in Type 1 (insulin-dependent) diabetes mellims. Many patients with Type 1 diabetes possess humoral auto-antibodies directed against the islet-cell cytoplasm [1] and/or antibodies directed against the surface of the islet B cells [2] . Patients with Type I diabetes often exhibit a positive reaction in the leucocyte migration test using different pancreatic homogenates [3] . Various immunological phenomena have been described, in which Type I diabetic subjects differ from healthy control individuals. For example, there is reduced suppressor cell activity at the time of diagnosis [4] , and an increase in the number of K cells [5] . The EMC virus has been shown to be diabetogenic in several mouse strains, with quite large variation within and between strains [6] . Earlier studies in the C57 mouse strain demonstrated a lack of diabetogenic effect by the EMC virus on athymic nude mice, whereas abnormal glucose tolerance curves were obtained from heterozygous littermates, and from homozygous normal mice [71.
The present investigation utilized BALB/c mice and included an evaluation of blood glucose, virus studies, virus antibody determinations, and histological investigation. The effect of immunosuppressive treatment with a derivative of cyclophosphamide was also studied.
Materials and Methods
Two strains of mice were investigated: (1) 145 approximately 8-weekold, normal, haired, male BALB/c/BOM mice, and (2) 29 approximately 8-week-old, nu/nu, male BALB/c/BOM mice (llth backcross generation of a gene transfer to BALB/c/BOM). The mice were divided into the following treatment groups: group 1:46 normal mice injected with virus in a concentration and amount described below; group 2:25 normal mice injected with one-tenth of the amount of virus employed for group I (dissolved in the same volume of vehicle); group 3:20 normal mice injected with 1/1000th of the amount of virus employed for group 1 (dissolved in the same volume of vehicle); group4:20 normal mice injected with virus as in group3 but also treated with suphosphamide (Cytimun, Asta/Schering, Copenhagen, 0012-186X/83/0024/0042/$01.00 All of the mice were purchased from G1. Bomholtgaard Laboratory, Animal Breeding and Research Centre, Ry, Denmark. The mice were reared under specified-pathogen-free conditions and were kept during experiments under conventional conditions at the Royal Veterinary and Agricultural University, Copenhagen. Autoclaved food pellets (GI. Bomholtgaard) and sterile drinking water were provided ad libitum. The mice were observed daily during the first 3 weeks and at longer intervals thereafter. Occurrence of glycosuria as well as paresis were recorded.
Virus, Virus Assay and Virus Inoculation
An M-strain of the encephalomyocarditis virus, kindly supplied by Dr. J. E. Craighead, known to be diabetogenic [8] , was used. The same strain has been used in two earlier investigations [7, 9] . A sixth passage batch of virus was titrated in L cells (established cell line of mouse fibroblasts) to a titre of 1055TCIDs0 (tissue culture infective doses)/ml. All of the mice were inoculated subcutaneously with 0.2 ml vehicle, for group 1 mice this contained 104.o TCIDs0. Control animals were inoculated with the suspension medium alone.
Immunosuppression
Group 4 and some group 6 mice were treated with suphosphamide (Cytimun, Asta/Schering, Copenhagen, Denmark). This compound is a derivative of cyclophosphamide and is pharmacologically immunosuppressive. Following virus administration each mouse was injected IP daily for 6 days with 0.5 ml of a solution containing 1 mg/ml suphosphamide in physiological saline. Fresh solutions were prepared daily.
Animal Sacrifice
The mice were anaesthetized with ether and then bled to death by cutting the axillary vein and artery. Immediately thereafter, the pancreas and heart were removed. The blood collected during sacrifice was analyzed enzymatically for blood glucose concentration using a glucose oxidase method [10] . Glycosuria was determined with Testape (Lilly, Indianapolis, Indiana, USA). Heart and pancreas tissues removed after sacrifice were placed in Hanks' buffer and homogenized immediately in a sand mortar. The amount of virus present was determined by titration in L cell cultures employing tenfold dilution steps and three cultures per dilution. Each value represents one mouse ( Fig. 1) .
Virus Antibodies
The mice were examined for the presence of neutralizing antibodies against EMC virus. The blood examined during the first 3 weeks was derived from sacrificed mice, and thereafter from blood samples of about 100 ~1 withdrawn from the paraorbital venous plexus. Each antibody determination was carried out as a neutralization test performed in L cell cultures against 100 IDs0 (infective doses) of EMC vires. Serial dilutions with a factor of 5 were each inoculated (three cultures per dilution). Each value represents one mouse ( Figs. 2 and 3) .
Light Microscope Studies
The tail of the pancreas was removed from the remainder of the gland after animal sacrifice and immediately fixed in 10% buffered formalin and embedded in paraffin. Sections (5ix thick) were cut and stained with haematoxylin-eosin, and examined without knowledge of which group the mouse belonged to. Twelve diabetic mice, 15 non-diabeticvirus-infected mice and 10 control mice were studied. The diabetic mice were examined, as soon as diabetes was established, between 6 and 10 days after the virus inoculation.
Electron Microscope Studies
Immediately after removal of the gland, approximately t mm 3 of the caudal pancreas was fixed in phosphate-buffered, 3% glutaraldehyde (pH 7.4). The specimens were postfixed in 1% OsO4, dehydrated in alcohol, embedded in Epon (Bie & Berntsen, Copenhagen, Denmark), sectioned with a diamond knife and stained with uranyl acetate and lead citrate. The specimens were examined with a Hitachi 7 S electron microscope.
Statistical Analyses
Experimental data are presented as mean _+ SEM. The significance of differences was evalutated by Fisher's exact test or by the MannWhitney U-test. The level of type 1 error (2a) was 0.05.
Results

Clinical Observations and Blood Glucose Determinations
Results are presented in Table 1 . Fourteen mice in group 1 and seven mice in group 2 developed glycosuria. These mice composed 36% and 28%, respectively, of the total number of mice in the two groups when the 8 first mouse became diabetic. These findings are signifi-7 cantly different from all of the remaining groups, in 6- which none of the mice developed glycosuria (p < 0.01, p < 0.05, respectively). Group 1 mice developed glycos-~ ~-uria 5-10 days after virus inoculation (mean blood glu-~ 4-cose 23 + 3 mmol/1), whereas the blood glucose level 3-on sacrifice of the rest of the mice in group 1 (which did
~ A large proportion of the normal mice inoculated with virus (groups 1-4) developed paresis, while this did not occur in any of the nude or control mice. The paresis affected one or both rear legs, and even occurred in the front legs in some mice, in which case the animal was sacrificed. Ninety-three percent of the mice in group 1 developed paresis. This was significantly higher 8-than in group 3 (p < 0.002), group 4 (p < 0.02) and the 7-control group (p < 0.002). A similar proportion (84%) 6 of the mice in group 2 also developed paresis, which ~ s was significantly greater than in group 3 and the control group (both p < 0.002), but not significantly different ~ a from group 4, in which 63% became paralysed. Despite 3 the fact that both group 3 and group 4 mice were inject-2 ed with the same dosage of virus, significantly fewer mice in group3 (24%) developed paresis than in group 4, where the animals were also treated with suphosphamide (p < 0.05). The percentage of mice with paresis in group 4 was significantly higher than in the control group (p < 0.002), which was not the case for 8 the mice in group 3 (0.05 < p < 0.10). The paresis ap-7 peared between days 4 and 10 in group 1 (mean 5 _+ 1 6 days) and up to day 14 in group 3 (mean 9 _+ 2 days), ff s Among the immunosuppressed mice paresis appeared ~-as late as 67 days after inoculation (mean 17 + 5 days).
-~ ~ 3.
Thus, while paresis occurred in a substantial proportion of the normal mice, it did not develop at all in 2 the nude mice. Immunosuppressive treatment increased the number of paralysed mice.
Virus Cultivations
The cultivation results on heart and pancreas from mice in groups 1, 3-5 are displayed logarithmically in Figure 1. In group 1 mice (Fig. 1 A) virus could be demonstrated in the pancreas already on the first day after virus inoculation, the maximum titre was detected after 4 days, and the last positive finding was 18 days after virus injection. In group 3 mice (Fig. 1 B) the first virus demonstration occurred 7 days after virus inoculation which also was the time of the measured maximum titre, while the last positive isolation occurred after 18 days. Group 4 mice (Fig. 1 C) , which also received suphosphamide, exhibited a somewhat different picture.
The maximum titre was found after 10-14 days, and quite a high titre was still present 23 days after inoculation. In the nude mice (group 5, Fig. 1 D) the maximum titre was observed in the pancreas 4 days after injection and in the heart tissue 8 days after injection. As late as 23 days after injection virus could still be demonstrated in nude mice. Thus, virus in abundant amounts could be demonstrated in all types of mice that were inoculated, even the nude mice which were not clinically affected. The earliest virus demonstrations were obtained from mice that were injected with a relatively large dosage of virus, and virus cultivation of the longest time after inoculation were obtained from immuno-defective mice (nude mice) and immunosuppressed mice. All attempts to demonstrate virus in control mice were negative.
Virus Antibody Determinations
The results of antibody studies on normal mice (group 1) and nude mice (group 5), which both received the same high dosage of virus, are presented in Figure 2 . Both nude and normal mice began producing measurable amounts of antibody 1 week after virus inoculation. Antibody formation in nude mice was small and remained detectable for only 15 days. On the other hand, normal mice produced relatively large amounts of antibody but then diminished markedly after 2-3 weeks, followed by a titre increase. Even 8 months after the virus inoculation, a relatively high titre of antibody could still be detected. Figure 3 shows the results of antibody measurements from groups 3 and 4, which both had been inoculated with relatively low dosages of virus. The curve for group3 mice resembles the corresponding curve for group 1 mice. The mice in group 4, which additionally received immunosuppressive treatment, did not produce measurable antibodies until after 23 days and they became negative again after 67 days.
Histological Studies
By light microscopy no difference was found between the virus treated, diabetic or non-diabetic mice, and the control mice, with respect to the number of lymphocytes in the islets of Langerhans. Apart from a few lymphocytes detected in one or more of the islets in less than 15% of the examined mice, randomly distributed among the different groups, including the control group, no lymphocytic infiltration was seen.
By electron microscopy some of the islet B-cells in the diabetic mice were found to contain fewer granules than B-cells from the control mice. In diabetic mice myelin bodies were seen in acinar cells as welt as in B-cells, almost exclusively in mitochondria. No macrophages or frank necrosis were observed.
Discussion
The present investigation has shown that athymic nude mice do not -in contrast to a substantial proportion of normal mice -develop diabetes mellitus after infection with EMC virus despite the demonstration that both the nude as well as the normal mice were unequivocally infected. Therefore, it seems reasonable to assume that diabetes may result as a reaction of the thymus-dependent immunological system to the virus infection, rather than as a result of the virus infection per se.
This conclusion is consistent with a similar investigation which used C57 mice. Nude C57 mice -in con-trast to normal C57 mice -did not develop glucose intolerance after infection with EMC virus [7] . Also a later study by Jansen et al. found no development of diabetes in nude mice of BALB/c origin in contrast to normal mice of the same strain [11] . This study did not mention any viral measurements or histology. However, although these findings are confirmed we have found important differences between C57 and BALB/c mice. C57 mice developed less severe glucose intolerance compared with the BALB/c mice. Another major difference between BALB/c and C57 mice, after injection with the same amount of EMC virus, appeared to be the time of emergence of the diabetic state, appearing about I week after injection in BALB/c mice. At this time virus in abundant amounts could be detected, but no virus could be demonstrated in C57 mice when they developed diabetes about 2-3 weeks after inoculation [9] .
Immunosuppressive treatment of mice with suphosphamide seemed to increase the proportion of mice which became paralysed. In a similar study using DBA2 mice, none of the mice showed paresis, but increased blood glucose values were seen when a cyclophosphamide derivative was given together with EMC virus [12] . It is known that suppressor cells are particularly sensitive to cyclophosphamide treatment [13, 14] , and it can therefore be suggested that the increased percentage of paralysed mice could result from an inhibiting effect of suphosphamide on suppressor cells. This would be in accordance with the observation that the spontaneous development of autoimmune disease in NZB mice may depend on a deficiency of suppressor cells [15] .
No significant lymphocyte infiltration was found in histological examinations of pancreas tissue from the diabetic mice in the present investigation. In CD-a mice a moderate infiltration of mononuclear cells has been found after EMC virus injection [16, 17] . The infiltrate was found only in some of the islets, mostly in the periphery and in the surrounding tissue, including the vessels [16] .
It can be concluded that, although the thymus-dependent immune system seems to be of decisive importance for the development of diabetes in this virus model, the primary mechanism for affecting the islet B cells seems not to be a massive lymphocytic infiltration in the islets. The involvement of other immunological mechanisms than a classical type IV reaction should therefore be considered.
